Mirae Asset Global Investments
RMD icon

Mirae Asset Global Investments’s ResMed RMD Stock Holding History

Mirae Asset Global Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.25M Buy
32,081
+492
+2% +$102K 0.01% 553
2026
Q1 		$7.09M Buy
31,589
+7,779
+33% +$1.94M ﹤0.01% 455
2025
Q4 		$5.74M Buy
23,810
+4,541
+24% +$1.16M 0.02% 517
2025
Q3 		$5.27M Buy
19,269
+2,414
+14% +$659K 0.02% 507
2025
Q2 		$4.35M Buy
16,855
+1,440
+9% +$343K 0.02% 503
2025
Q1 		$3.39M Buy
15,415
+2,585
+20% +$603K 0.01% 540
2024
Q4 		$2.99M Buy
12,830
+3,576
+39% +$861K 0.01% 551
2024
Q3 		$2.21M Buy
9,254
+2,212
+31% +$494K 0.01% 603
2024
Q2 		$1.35M Sell
7,042
-33,713
-83% -$6.84M 0.01% 677
2024
Q1 		$8.58M Sell
40,755
-4,476
-10% -$820K 0.02% 695
2023
Q4 		$7.78M Buy
45,231
+5,517
+14% +$848K 0.02% 738
2023
Q3 		$5.87M Sell
39,714
-2,845
-7% -$514K 0.01% 819
2023
Q2 		$9.3M Sell
42,559
-3,159
-7% -$704K 0.02% 683
2023
Q1 		$10M Sell
45,718
-2,689
-6% -$583K 0.02% 646
2022
Q4 		$10.1M Buy
48,407
+17,256
+55% +$3.79M 0.03% 596
2022
Q3 		$6.8M Buy
31,151
+3,470
+13% +$790K 0.02% 701
2022
Q2 		$5.8M Buy
27,681
+5,439
+24% +$1.16M 0.01% 796
2022
Q1 		$5.39M Buy
22,242
+3,768
+20% +$911K 0.01% 849
2021
Q4 		$4.81M Buy
18,474
+4,062
+28% +$1.05M 0.01% 895
2021
Q3 		$3.8M Buy
14,412
+2,619
+22% +$716K 0.01% 931
2021
Q2 		$2.91M Buy
11,793
+1,679
+17% +$353K 0.01% 958
2021
Q1 		$1.96M Sell
10,114
-5,007
-33% -$1M 0.01% 961
2020
Q4 		$3.21M Buy
15,121
+2,464
+19% +$491K 0.01% 774
2020
Q3 		$2.17M Sell
12,657
-1,131
-8% -$209K 0.01% 765
2020
Q2 		$2.65M Buy
13,788
+2,383
+21% +$390K 0.02% 636
2020
Q1 		$1.68M Buy
11,405
+438
+4% +$69.8K 0.01% 686
2019
Q4 		$1.7M Buy
10,967
+3,024
+38% +$436K 0.01% 786
2019
Q3 		$1.07M Buy
7,943
+1,278
+19% +$167K 0.01% 893
2019
Q2 		$813K Sell
6,665
-1,918
-22% -$212K 0.01% 972
2019
Q1 		$892K Sell
8,583
-980
-10% -$101K 0.01% 879
2018
Q4 		$1.09M Sell
9,563
-1,709
-15% -$183K 0.01% 745
2018
Q3 		$1.3M Buy
11,272
+8,075
+253% +$885K 0.01% 766
2018
Q2 		$331K Sell
3,197
-13
-0.4% -$1.31K ﹤0.01% 683
2018
Q1 		$317K Sell
3,210
-128
-4% -$12.1K ﹤0.01% 641
2017
Q4 		$283K Buy
+3,338
New +$276K ﹤0.01% 630
2017
Q3 		– Sell
-3,291
Closed -$256K – 681
2017
Q2 		$256K Sell
3,291
-1,592
-33% -$114K ﹤0.01% 599
2017
Q1 		$352K Buy
+4,883
New +$337K 0.01% 523
2016
Q4 		– Sell
-3,152
Closed -$204K – 550
2016
Q3 		$204K Buy
+3,152
New +$210K ﹤0.01% 514

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Mirae Asset Global Investments's RMD Position: Q2 2026 in Review

Mirae Asset Global Investments increased its ResMed (RMD) stake by 1.6% in Q2 2026, buying an estimated $102K and bringing the position to 32,081 shares worth $6.25M. The position accounts for 0.01% of the portfolio, ranked #553.

Mirae Asset Global Investments first reported a position in RMD in Q3 2016 and has held it in 38 quarters since. The position peaked at $10.1M in Q4 2022. 449 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Mirae Asset Global Investments held 32,081 shares of ResMed worth $6.25M as of Q2 2026.
  • Mirae Asset Global Investments bought 492 ResMed shares in Q2 2026, an estimated $102K.
  • ResMed made up 0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #553 holding.
  • Mirae Asset Global Investments first reported a position in ResMed in Q3 2016 and has held it in 38 quarters since.
  • Mirae Asset Global Investments's ResMed position peaked at $10.1M in Q4 2022.
  • 449 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.